Historical daily share price chart and data for EYEPOINT PHARMACEUTICALS, INC since 2021 adjusted for splits. The latest closing stock price for EYEPOINT PHARMACEUTICALS, INC as of September 27, 2021 is 11.46.
  • The all-time high EYEPOINT PHARMACEUTICALS, INC stock closing price was 37.70 on October 03, 2018.
  • The EYEPOINT PHARMACEUTICALS, INC 52-week high stock price is 15.06, which is 31.4% above the current share price.
  • The EYEPOINT PHARMACEUTICALS, INC 52-week low stock price is 3.51, which is 69.4% below the current share price.
  • The average EYEPOINT PHARMACEUTICALS, INC stock price for the last 52 weeks is 8.70.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
EYEPOINT PHARMACEUTICALS, INC Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 8.5463 15.3000 20.5000 3.7230 6.5800 -57.55%
2019 18.4179 19.5000 27.2000 12.4000 15.5000 -17.99%
2018 22.2384 11.5000 37.7000 11.4000 18.9000 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.330B $0.034B
EyePoint Pharmaceuticals Inc. operates as a biopharmaceutical company. It engaged in the development of drug devices to treat debilitating diseases of the eye disorders and other chronic conditions. The company's product candidate consists of DEXYCU(TM). EyePoint Pharmaceuticals Inc., formerly known as pSivida Corp., is headquartered in Watertown, MA.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29